ea0063p838 | Adrenal and Neuroendocrine Tumours 3 | ECE2019
Mazo Estefania Santos
, Lanchas Isabel
, Begona Miguel
, Barrio Javier Pi
, Crespo Guillermo
, Moreira Manuela
, Garcia-Hierro Victor
, Manuel Javier Sanchez
Retrospective study of patients with metastatic/progressive pheochromocytoma (PCC) and paraganglioma (PGL) treated with (131) I MIBG in our hospital during 20152018 period.Methods: There are no established criteria for establishing PCC/PGL as malignant apart from de presence of metastases at diagnosis. Radionuclide therapy (131) I-metaiodobenzylguanidine (MIBG) is frequently used in this patients when surgery is not possible. Indication of MIBG tre...